Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Intra-Cellular Therapies Total Assets 2013-2020 | ITCI

Intra-Cellular Therapies total assets from 2013 to 2020. Total assets can be defined as the sum of all assets on a company's balance sheet.
  
Intra-Cellular Therapies Annual Total Assets
(Millions of US $)
2019 $251
2018 $357
2017 $471
2016 $389
2015 $484
2014 $131
2013 $38
2012 $20
Intra-Cellular Therapies Quarterly Total Assets
(Millions of US $)
2020-09-30 $771
2020-06-30 $441
2020-03-31 $481
2019-12-31 $251
2019-09-30 $281
2019-06-30 $310
2019-03-31 $343
2018-12-31 $357
2018-09-30 $386
2018-06-30 $412
2018-03-31 $446
2017-12-31 $471
2017-09-30 $334
2017-06-30 $350
2017-03-31 $372
2016-12-31 $389
2016-09-30 $543
2016-06-30 $448
2016-03-31 $464
2015-12-31 $484
2015-09-30 $513
2015-06-30 $213
2015-03-31 $237
2014-12-31 $131
2014-09-30 $138
2014-06-30 $141
2014-03-31 $147
2013-12-31 $38
2013-09-30 $47
2013-06-30 $0
2013-03-31 $0
2012-12-31 $0
2012-09-30 $0
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $2.082B $0.000B
Intra-Cellular Therapies Inc. is a biopharmaceutical company. The company develops drugs for the treatment of neuropsychiatric and neurologic diseases and other disorders of the central nervous system. Its product candidates include ITI-007, ITI-002 and ITI-009 which is in clinical trials. Intra-Cellular Therapies Inc. is headquartered in New York.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $140.490B 10.02
Amgen (AMGN) United States $130.796B 13.67
CSL (CSLLY) Australia $103.933B 0.00
Gilead Sciences (GILD) United States $76.001B 10.10
Vertex Pharmaceuticals (VRTX) United States $55.120B 25.63
Regeneron Pharmaceuticals (REGN) United States $54.923B 19.48
Illumina (ILMN) United States $43.654B 60.04
Biogen (BIIB) United States $37.549B 6.67
Moderna (MRNA) United States $36.710B 0.00
Seagen (SGEN) United States $31.440B 83.03
Alexion Pharmaceuticals (ALXN) United States $26.710B 10.64
BeiGene (BGNE) Cayman Islands $25.597B 0.00
Genmab (GMAB) Denmark $23.665B 28.01
Genmab (GNMSF) Denmark $22.484B 5.18
BioNTech SE (BNTX) Germany $21.479B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $18.127B 0.00
Incyte (INCY) United States $17.890B 0.00
Bio-Rad Laboratories (BIO.B) United States $17.776B 67.41
Exact Sciences (EXAS) United States $17.025B 0.00
Horizon Therapeutics Public (HZNP) Ireland $15.690B 22.43
Alnylam Pharmaceuticals (ALNY) United States $14.384B 0.00
BioMarin Pharmaceutical (BMRN) United States $13.638B 90.52
ARGENX SE-ADR (ARGX) Netherlands $12.417B 0.00
Bio-Techne Corp (TECH) United States $11.670B 74.63
Mirati Therapeutics (MRTX) United States $11.407B 0.00
Guardant Health (GH) United States $10.848B 0.00
QIAGEN (QGEN) Netherlands $10.766B 24.24
Sarepta Therapeutics (SRPT) United States $10.607B 0.00
Repligen (RGEN) United States $9.855B 139.77
ACADIA Pharmaceuticals (ACAD) United States $8.523B 0.00
Galapagos (GLPG) Belgium $8.062B 0.00
Ascendis Pharma (ASND) Denmark $7.990B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $7.718B 0.00
Denali Therapeutics (DNLI) United States $7.405B 0.00
Ultragenyx Pharmaceutical (RARE) United States $6.887B 0.00
Acceleron Pharma (XLRN) United States $6.683B 0.00
Adaptive Biotechnologies (ADPT) United States $6.225B 0.00
Exelixis (EXEL) United States $5.895B 39.58
Amicus Therapeutics (FOLD) United States $5.660B 0.00
Reata Pharmaceuticals (RETA) United States $5.550B 0.00
Novavax (NVAX) United States $5.500B 0.00
Blueprint Medicines (BPMC) United States $5.390B 17.84
SWEDISH ORP BIO (BIOVF) Sweden $5.385B 14.71
Halozyme Therapeutics (HALO) United States $5.214B 241.06
Twist Bioscience (TWST) United States $5.114B 0.00
NeoGenomics (NEO) United States $4.744B 1424.33
China Biologic Products (CBPO) China $4.664B 27.69
Fate Therapeutics (FATE) United States $4.337B 0.00
Emergent Biosolutions (EBS) United States $4.270B 14.01
Insmed (INSM) United States $4.047B 0.00
Arena Pharmaceuticals (ARNA) United States $3.826B 0.00
Vir Biotechnology (VIR) United States $3.659B 0.00
Deciphera Pharmaceuticals (DCPH) United States $3.643B 0.00
Legend Biotech (LEGN) United States $3.509B 0.00
MorphoSys AG (MOR) Germany $3.473B 125.71
Eidos Therapeutics (EIDX) United States $3.105B 0.00
Bluebird Bio (BLUE) United States $2.931B 0.00
Seres Therapeutics (MCRB) United States $2.925B 0.00
Alkermes (ALKS) Ireland $2.892B 28.39
Global Blood Therapeutics (GBT) United States $2.686B 0.00
I-Mab (IMAB) China $2.298B 0.00
Beam Therapeutics (BEAM) United States $2.291B 0.00
UniQure (QURE) Netherlands $2.054B 0.00
PHARMA MAR SA (PHMMF) Spain $2.028B 0.00
Sorrento Therapeutics (SRNE) United States $2.011B 0.00
Viela Bio (VIE) United States $1.914B 0.00
Intellia Therapeutics (NTLA) United States $1.906B 0.00
Zymeworks (ZYME) Canada $1.902B 0.00
Inovio Pharmaceuticals (INO) United States $1.867B 0.00
Amarin (AMRN) Ireland $1.775B 0.00
Editas Medicine (EDIT) United States $1.747B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.713B 0.00
Revance Therapeutics (RVNC) United States $1.624B 0.00
Mersana Therapeutics (MRSN) United States $1.608B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $1.607B 13.30
NGM Biopharmaceuticals (NGM) United States $1.605B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.594B 0.00
Arcus Biosciences (RCUS) United States $1.578B 0.00
Sangamo Therapeutics (SGMO) United States $1.460B 0.00
Alcobra (ARCT) United States $1.454B 0.00
Zealand Pharma (ZEAL) Denmark $1.434B 0.00
Mesoblast (MESO) Australia $1.383B 0.00
REGENXBIO (RGNX) United States $1.368B 0.00
Scholar Rock Holding (SRRK) United States $1.346B 0.00
Ligand Pharmaceuticals (LGND) United States $1.311B 33.97
Athenex (ATNX) United States $1.303B 0.00
Myriad Genetics (MYGN) United States $1.293B 0.00
Coherus BioSciences (CHRS) United States $1.291B 8.53
Zealand Pharma (ZLDPF) Denmark $1.289B 0.00
Adverum Biotechnologies (ADVM) United States $1.236B 0.00
Intercept Pharmaceuticals (ICPT) United States $1.229B 0.00
Heska (HSKA) United States $1.167B 0.00
Epizyme (EPZM) United States $1.150B 0.00
Precigen (PGEN) United States $1.139B 0.00
Cytokineticsorporated (CYTK) United States $1.121B 0.00
Vericel (VCEL) United States $1.074B 0.00
Northwest Biotherapeutics (NWBO) United States $1.050B 0.00
Genetron Holdings (GTH) China $1.025B 0.00
Alector (ALEC) United States $0.979B 0.00
Codexis (CDXS) United States $0.976B 0.00
Pliant Therapeutics (PLRX) United States $0.971B 0.00
Arvinas (ARVN) United States $0.947B 0.00
Cellectis S.A (CLLS) France $0.939B 0.00
NantKwest (NK) United States $0.923B 0.00
Castle Biosciences (CSTL) United States $0.921B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.911B 0.00
Morphic Holding (MORF) United States $0.908B 0.00
Compugen (CGEN) Israel $0.883B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.880B 0.00
Protagonist Therapeutics (PTGX) United States $0.823B 0.00
Frequency Therapeutics (FREQ) United States $0.815B 0.00
Cara Therapeutics (CARA) United States $0.794B 0.00
Celldex Therapeutics (CLDX) United States $0.791B 0.00
MiMedx (MDXG) United States $0.754B 0.00
Pharming Group (PHGUF) Netherlands $0.751B 17.14
AnaptysBio (ANAB) United States $0.718B 0.00
Agenus (AGEN) United States $0.713B 0.00
Five Prime Therapeutics (FPRX) United States $0.691B 0.00
Sutro Biopharma (STRO) United States $0.688B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.682B 34.64
Kadmon Holdings (KDMN) United States $0.669B 0.00
Albireo Pharma (ALBO) United States $0.665B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.663B 0.00
MannKind (MNKD) United States $0.642B 0.00
VBI Vaccines (VBIV) United States $0.641B 0.00
Sinovac Biotech (SVA) China $0.640B 43.13
Adaptimmune Therapeutics (ADAP) United Kingdom $0.614B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.598B 0.00
Cardiff Oncology (CRDF) United States $0.589B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.587B 0.00
Geron (GERN) United States $0.571B 0.00
Anika Therapeutics (ANIK) United States $0.519B 70.27
Aquinox Pharmaceuticals (NLTX) United States $0.512B 0.00
Forte Biosciences (FBRX) United States $0.508B 0.00
Precision BioSciences (DTIL) United States $0.508B 0.00
IVERIC Bio (ISEE) United States $0.507B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.505B 0.00
Avid Bioservices (CDMO) United States $0.504B 0.00
MeiraGTx Holdings (MGTX) United States $0.496B 0.00
Dynavax Technologies (DVAX) United States $0.490B 0.00
Prothena (PRTA) Ireland $0.471B 0.00
Amryt Pharma (AMYT) United Kingdom $0.454B 0.00
UROGEN PHARMA (URGN) United States $0.452B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.449B 0.00
Cel-Sci (CVM) United States $0.439B 0.00
Merus (MRUS) Netherlands $0.436B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.432B 0.00
WAVE Life Sciences (WVE) Singapore $0.428B 0.00
Kala Pharmaceuticals (KALA) United States $0.426B 0.00
BioDelivery Sciences (BDSI) United States $0.415B 19.52
Innate Pharma S.A (IPHA) France $0.402B 0.00
Spero Therapeutics (SPRO) United States $0.402B 0.00
Puma Biotechnology (PBYI) United States $0.400B 0.00
Starpharma Holdings (SPHRY) Australia $0.397B 0.00
Trevena (TRVN) United States $0.385B 0.00
Cue Biopharma (CUE) United States $0.385B 0.00
AC Immune SA (ACIU) Switzerland $0.380B 0.00
Clovis Oncology (CLVS) United States $0.379B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.369B 0.00
Affimed (AFMD) Germany $0.368B 0.00
Syros Pharmaceuticals (SYRS) United States $0.361B 0.00
Cellular Biomedicine (CBMG) United States $0.357B 0.00
XOMA (XOMA) United States $0.355B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.347B 0.00
Selecta Biosciences (SELB) United States $0.346B 0.00
ANI Pharmaceuticals (ANIP) United States $0.344B 8.76
CytomX Therapeutics (CTMX) United States $0.343B 0.00
Athersys (ATHX) United States $0.306B 0.00
ChromaDex (CDXC) United States $0.303B 0.00
Kamada (KMDA) Israel $0.297B 13.92
IBio (IBIO) United States $0.295B 0.00
Arbutus Biopharma (ABUS) United States $0.284B 0.00
PDL BioPharma (PDLI) United States $0.282B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.281B 0.00
NextCure (NXTC) United States $0.275B 0.00
DBV Technologies S.A (DBVT) France $0.259B 0.00
Fortress Biotech (FBIO) United States $0.259B 0.00
Verastem (VSTM) United States $0.250B 0.00
HOOKIPA Pharma (HOOK) United States $0.238B 0.00
TELA Bio (TELA) United States $0.237B 0.00
Pluristem Therapeutics (PSTI) Israel $0.235B 0.00
CorMedix Inc (CRMD) United States $0.219B 0.00
Aptinyx (APTX) United States $0.201B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.195B 0.00
Bellus Health (BLU) Canada $0.192B 0.00
Aptevo Therapeutics (APVO) United States $0.189B 0.00
POXEL SA FRANCE (PXXLF) France $0.185B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.182B 0.00
Dyadic (DYAI) United States $0.181B 0.00
Eton Pharmaceuticals (ETON) United States $0.178B 0.00
Theratechnologies (THTX) Canada $0.178B 0.00
AquaBounty Technologies (AQB) United States $0.174B 0.00
Strongbridge Biopharma (SBBP) United States $0.173B 0.00
Cerecor (CERC) United States $0.172B 0.00
ADMA Biologics Inc (ADMA) United States $0.170B 0.00
Nicox SA (NICXF) France $0.170B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.169B 0.00
Checkpoint Therapeutics (CKPT) United States $0.168B 0.00
VolitionRX (VNRX) United States $0.166B 0.00
Biofrontera AG (BFRA) Germany $0.163B 0.00
GENFIT S.A (GNFT) France $0.160B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.153B 0.00
Oncobiologics (OTLK) United States $0.153B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.152B 0.00
SESEN BIO, INC (SESN) United States $0.149B 0.00
Kindred Biosciences (KIN) United States $0.148B 0.00
VTv Therapeutics (VTVT) United States $0.138B 0.00
Lumos Pharma (LUMO) United States $0.133B 0.00
Abeona Therapeutics (ABEO) United States $0.132B 0.00
Prometic Life Sciences (LMNL) Canada $0.130B 0.00
Protalix BioTherapeutics (PLX) Israel $0.130B 0.00
Liquidia Technologies (LQDA) United States $0.128B 0.00
Exicure (XCUR) United States $0.128B 0.00
Catalyst Biosciences (CBIO) United States $0.127B 0.00
Idera Pharmaceuticals (IDRA) United States $0.127B 0.00
Celyad SA (CYAD) Belgium $0.123B 0.00
Antibe Therapeutics (ATBPF) Canada $0.121B 0.00
TRACON Pharmaceuticals (TCON) United States $0.117B 0.00
Aytu Bioscience (AYTU) United States $0.116B 0.00
Orgenesis (ORGS) United States $0.114B 235.00
Novogen (KZIA) Australia $0.114B 0.00
Cogent Biosciences (COGT) United States $0.112B 0.00
Windtree Therapeutics (WINT) United States $0.110B 0.00
Cidara Therapeutics (CDTX) United States $0.109B 0.00
PhaseBio Pharaceuticals (PHAS) United States $0.108B 0.00
Applied Genetic Technologies (AGTC) United States $0.105B 0.00
Gritstone Oncology (GRTS) United States $0.103B 0.00
Cyclerion Therapeutics (CYCN) United States $0.103B 0.00
Palatin Technologies (PTN) United States $0.100B 0.00
AIT Therapeutics (XAIR) United States $0.095B 0.00
Enzo Biochem (ENZ) United States $0.094B 0.00
ARAVIVE, INC (ARAV) United States $0.091B 0.00
Clearside Biomedical (CLSD) United States $0.086B 0.00
Ecology Coatings (ABVC) United States $0.083B 0.00
DiaMedica Therapeutics (DMAC) United States $0.080B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.078B 0.00
Bionano Genomics (BNGO) United States $0.077B 0.00
Stealth BioTherapeutics (MITO) United States $0.077B 37.00
Curis (CRIS) United States $0.076B 0.00
Prima BioMed (IMMP) Australia $0.074B 0.00
Synlogic (SYBX) United States $0.072B 0.00
Soligenix (SNGX) United States $0.072B 0.00
Evogene (EVGN) Israel $0.072B 0.00
MiRagen Therapeutics (MGEN) United States $0.072B 0.00
Adocia (ADOCY) France $0.067B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.061B 0.00
Cocrystal Pharma (COCP) United States $0.061B 0.00
Organovo Holdings (ONVO) United States $0.060B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.060B 0.00
Armata Pharmaceuticals (ARMP) United States $0.059B 0.00
Proteostasis Therapeutics (PTI) United States $0.056B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.055B 0.00
Emmaus Life Sciences (EMMA) United States $0.053B 0.00
Appili Therapeutics (APLIF) Canada $0.053B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.052B 0.00
Vascular Biogenics (VBLT) Israel $0.050B 0.00
Happiness Biotech Group (HAPP) China $0.049B 0.00
Edesa Biotech (EDSA) Canada $0.047B 0.00
Vaccinex (VCNX) United States $0.044B 0.00
CollPlant Holdings (CLGN) Israel $0.044B 0.00
Seelos Therapeutics (SEEL) United States $0.043B 0.00
IMMURON (IMRN) Australia $0.042B 0.00
Genetic Technologies (GENE) Australia $0.041B 0.00
Cleveland BioLabs (CBLI) United States $0.040B 0.00
AnPac Bio-Medical Science (ANPC) China $0.036B 0.00
Pulmatrix (PULM) United States $0.036B 0.00
Acorda Therapeutics (ACOR) United States $0.034B 0.00
Chanticleer Holdings (SONN) United States $0.034B 0.00
ATyr Pharma (LIFE) United States $0.034B 0.00
Titan Pharmaceuticals (TTNP) United States $0.034B 0.00
OvaScience (MLND) United States $0.032B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.028B 0.00
BioCardia (BCDA) United States $0.028B 0.00
Prana Biotechnology (ATHE) Australia $0.026B 0.00
Advaxis (ADXS) United States $0.026B 0.00
Alimera Sciences (ALIM) United States $0.024B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.023B 0.00
AEterna Zentaris (AEZS) United States $0.021B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.021B 0.00
Cesca Therapeutics (THMO) United States $0.020B 0.00
Celsion (CLSN) United States $0.019B 0.00
Spherix (AIKI) United States $0.018B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.017B 0.00
Invo BioScience (INVO) United States $0.016B 0.00
BioPharmX (TMBR) United States $0.011B 0.00
Neuralstem (SNCA) United States $0.011B 0.00
GeoVax Labs (GOVX) United States $0.011B 0.00
Benitec Biopharma (BNTC) Australia $0.003B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00
Osmotica Pharmaceuticals (OSMT) United States $0.000B 0.00
Zai Lab (ZLAB) China $0.000B 0.00